Symbiotec Pharmalab Limited IPO
About Symbiotec Pharmalab Limited
Incorporated in 2002, Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the research, development, and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products. The company serves a diverse customer base across domestic and international markets, with a presence in both regulated and emerging geographies.
IPO Details
1.31
₹938.00 - 988.00
15
₹14,820
IPO
BSE
INE899I01028
285 (28.85)
IPO Timeline
Subscription Details
912.5x
4.44x
18.67x
9.53x
Symbiotec Pharmalab Limited Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 15 | ₹14,820 |
| Retail (Max) | 1 | 15 | ₹14,820 |
| HNI (Min) | 2 | 30 | ₹29,640 |
FAQs on Symbiotec Pharmalab Limited IPO
What are allotment date for the Symbiotec Pharmalab Limited ?
Allotment: 28-08-2026
What are the open and close dates for the Symbiotec Pharmalab Limited IPO ?
Opens on 24-08-2026, closes on 27-08-2026.
Can NRIs apply for the Symbiotec Pharmalab Limited IPO through PL Capital?
Yes, NRIs can apply for the Symbiotec Pharmalab Limited IPO through PL Capital, subject to RBI and SEBI guidelines. Applications can be made via the NRE or NRO account route.
Where is the Symbiotec Pharmalab Limited IPO getting listed?
The Symbiotec Pharmalab Limited IPO will be listed on BSE. The exact listing date is 01-09-2026.
What is the minimum and maximum investment allowed in the Symbiotec Pharmalab Limited IPO?
The minimum investment for retail investors in the Symbiotec Pharmalab Limited IPO is ₹14,820. The maximum retail investment allowed is ₹14,820.
What is the GMP for this IPO?
Current GMP is 285 (28.85%)
